Gold Price Today, Nov 6, 2025: Spot Reclaims $4,000 as Dollar Softens—Traders Eye Fed Path, Shutdown & Tariff Ruling

Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

6 November 2025

Updated: 10:31 UTC on November 6, 2025.

Top line: Gold moved back above the psychologically important $4,000/oz mark in Thursday trade as the U.S. dollar eased from recent highs and investors weighed a prolonged U.S. government shutdown alongside shifting rate-cut odds and a U.S. Supreme Court case scrutinizing tariffs. As of 09:14 GMT, spot gold was around $4,011.79/oz and December futures near $4,021.20/oz. Silver, platinum and palladium also firmed. ^[1]

At a glance (Nov 6, 2025)

Spot gold (XAU/USD): ~$4,011.79 at 09:14 GMT; back above $4,000 as the dollar slips from a multi‑month peak. ^[2]
COMEX gold (Dec ’25): ~$4,021.20. ^[3]
Day’s range (intraday): ~$3,964–$4,017; 52‑week range: ~$2,537–$4,382. ^[4]
U.S. Dollar Index (DXY): down ~0.2% on the day. ^[5]
U.S. 10‑year Treasury yield: hovering near 4.13–4.15% intraday. ^[6]
Other precious metals: silver ~$48.7/oz (+~1.4%), platinum ~$1,567/oz (+~0.4%), palladium ~$1,434/oz (+~1.1%). ^[7]

Context: Gold’s all‑time high was set in October, briefly topping $4,381/oz before pulling back. ^[8]

What moved gold today

1) Softer dollar
The greenback eased from recent multi‑month highs, mechanically supporting dollar‑priced bullion. A 0.2% dip in DXY made gold cheaper for non‑U.S. buyers. ^[9]

2) U.S. shutdown and policy uncertainty
Markets continue to grapple with a prolonged U.S. government shutdown, now the longest on record, which is complicating macro visibility and keeping haven demand underpinned. ^[10]

3) Data & Fed expectations
Private payrolls for October rose 42,000 (ADP), above a Reuters poll (~28,000), trimming the market‑implied probability of another December rate cut to ~63%. A slightly cooler dollar and recalibrated rate bets combined to lift spot prices back over $4k. ^[11]

4) Trade/tariff overhang
Supreme Court justices voiced skepticism over the legality of broad tariffs, injecting another macro wild card that investors read as supportive for gold’s risk‑hedge appeal. ^[12]

How the session unfolded (times GMT)

Asia (early): Gold traded below $4,000—~$3,973/oz in Singapore—as the market digested prior dollar strength. ^[13]
Europe (morning): A softer dollar helped reclaim $4,000; spot near $4,012/oz by 09:14. ^[14]

Intraday ranges reflected two‑way flows, with $4,000 acting as a pivot; today’s low‑to‑high sat roughly in the $3,964–$4,017 band. ^[15]

Big picture: why $4k still matters

New regime since October: Gold first smashed through $4,000 on Oct 8 amid shutdown/sovereign‑risk concerns before notching a record later in the month. ^[16]
Central‑bank underpin:Q3-2025 central‑bank purchases stayed elevated at ~220t (YTD ~634t), reinforcing structural demand even at higher prices, per the World Gold Council. ^[17]
Macro pulse: Strategists remain split—UBS sees room back toward $4,200 if Fed easing resumes, while others warn of consolidation. ^[18]
Post‑election narrative: Since November 2024, gold has outperformed most assets as policy uncertainty and rate‑path debates intensified. ^[19]

Key levels & simple roadmap (today)

Immediate pivot:$4,000 (psychological & round‑number magnet).
Near resistance:$4,020–$4,050 (European session highs/round figures).
Near support:$3,960–$3,930 (overnight range floor; prior congestion).
Volatility drivers ahead:BoE decision at ~12:00 GMT, U.S. headlines on the shutdown and tariff case, plus any remarks from Fed officials that tweak cut odds. ^[20]

Note: Levels are indicative, based on today’s range and recent microstructure; they’re not trading advice.

Quick data panel

Metric	Snapshot	Source
Spot gold (09:14 GMT)	~$4,011.79/oz	Reuters
COMEX Dec ’25	~$4,021.20	Reuters
Intraday range	~$3,964–$4,017	Investing.com
52‑week range	~$2,537–$4,382	Investing.com
U.S. 10‑year yield	~4.13–4.15% intraday	Investing.com
Silver / Platinum / Palladium	~$48.7 / $1,567 / $1,434	Reuters

Figures are timestamped and may be delayed by ~10–15 minutes depending on the venue.

Citations for the table: ^[21]

Why it matters for readers

Portfolio ballast: Elevated real‑rate volatility and policy risk have kept gold’s hedge role front and center in 2025. WGC data confirms official‑sector buying remains robust. ^[22]
What could break the range: A decisive dollar trend (up or down), faster‑than‑expected Fed policy moves, or a legal/political shock (shutdown/tariff ruling) could push bullion out of the $3,95k–$4,05k near‑term corridor. ^[23]

Methodology & time stamp

This report synthesizes live spot (XAU/USD), COMEX futures, and macro drivers from primary financial newswires and price dashboards. All times are UTC and quotes are from the listed sources at their stated timestamps. Current UTC time used for this update: 10:31 on Nov 6, 2025.

This article is for informational purposes only and does not constitute investment advice.

Gold Rates Today LIVE | Price of 22 & 24 Carat Gold Today | Gold Price in India | 5 November 2025

Watch this video on YouTube.

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.investing.com, 5. www.reuters.com, 6. www.investing.com, 7. www.reuters.com, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.reuters.com, 12. www.reuters.com, 13. www.moneycontrol.com, 14. www.reuters.com, 15. www.investing.com, 16. www.bloomberg.com, 17. www.gold.org, 18. www.reuters.com, 19. www.barrons.com, 20. www.reuters.com, 21. www.reuters.com, 22. www.gold.org, 23. www.reuters.com

Tags:

Marcin Frąckiewicz Latest posts

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

View all

Snap Stock Surges 18% on $400 Million Perplexity AI Deal
November 6, 2025, 7:33 AM EST. Snap (SNAP) jumped 18% in pre-market after beating Q3 revenue estimates and announcing a $500 million stock buyback. Revenue rose to $1.51 billion, above expectations of $1.49B, while daily active users reached 477 million. The company inked a $400 million partnership with AI search startup Perplexity to embed its conversational search into Snapchat, starting in early 2026. The move diversifies revenue beyond ads, though the company warns about potential Q4 headwinds from Apple/Google age-verification changes and Australia's restrictions. Profitability improved, with net losses narrowing over 30% YoY and adjusted EBITDA of $182 million. Analysts' price targets and upside discussions remain mixed amid a year-to-date decline.
Is Elevance Health a Hidden Opportunity After a 24.5% Drop in 2025?
November 6, 2025, 7:28 AM EST. Elevance Health has tumbled in 2025 amid policy shifts and broader healthcare-sector volatility, with a year-to-date drawdown and a longer 24.5% slide that has investors rethinking value. The piece weighs near- and long-term catalysts, noting that a high valuation score isn't translating into certainty as government program changes loom for managed care. The core takeaway is a rigorous DCF assessment, which, using current free cash flow of $3.6B and projected growth, yields an intrinsic value around $1,090.84 per share-roughly 71% above current prices, signaling undervaluation. Still, equity investors should monitor the PE ratio, competitive dynamics, and policy risk, which could affect how quickly this perceived bargain translates into realized gains.
Inflammation Biotech Evommune Starts NYSE Trading in $150M IPO
November 6, 2025, 7:24 AM EST. Evommune is heading to the NYSE with a $150 million IPO to fund two clinical-stage assets. The Palo Alto biopharma is offering 9.3 million shares at $16 each, pricing in the $15-$17 range. Gross proceeds are $150 million, potentially rising by about $22.5 million if underwriters exercise their option for an additional 1.4 million shares. Trading under the ticker EVMN could begin today. The company plans to use the funds to advance two phase 2 programs, including EVO756, an oral MRGPRX2 antagonist being studied for CSU and atopic dermatitis (AD). Topline data for CSU from a phase 2 study showed 93% responses at four weeks. Data for AD topline in H2 2026. Evommune priced amid a broader biotech IPO backdrop as MapLight Therapeutics went public last week.
Arm Holdings Stock Surges on Q2 Beat, Strong AI Demand Lifts Outlook
November 6, 2025, 7:22 AM EST. Arm Holdings (ARM) stock jumps about 5-6% in pre-market trading after reporting a Q2 beat that topped revenue and earnings estimates and issuing stronger Q3 guidance. The company posted revenue of $1.14 billion, up 34% year over year, and EPS of $0.22, exceeds consensus of $0.13. Arm also raised its quarterly revenue guide to about $1.23 billion versus the $1.10 billion expected. Royalty revenue reached a record $620 million, up 21%, led by data centers, automotive, and IoT, with hyperscalers like Google, Amazon, and Microsoft boosting Arm-based deployments. Licensing revenue rose 56% to $515 million. The AI infrastructure buildout underscores demand for Arm's energy-efficient designs, and management hints at potential in-house chip development beyond licensing.
Capital One Stock Prediction: Analysts See Up to 29% Upside by 2027 on Discover Acquisition
November 6, 2025, 7:20 AM EST. Capital One (NYSE: COF) trades around $221 with an average target near $260, implying ~18% upside. Targets span $290 (high) and $210 (low), with a median near $258 and a mix of 14 Buys, 3 Outperforms, and 6 Holds. Growth projections call for revenue up about 19% annually through 2027, supported by operating margins near 48% and a forward multiple around 9.7x. A guided model points to ~$285/share by 2027, or about 29% total upside (12% annualized). The story centers on the Discover acquisition, expanded payments network, and stable credit trends amid solid consumer spending, though conviction remains modest and upside depends on continued earnings growth and credit stability.